Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
29 May, 2017 13:19 IST
Divis Lab receives import alert for Visakhapatnam facility
Source: IRIS | 21 Mar, 2017, 10.10AM
Comments  |  Post Comment

Divis Laboratories, a pharmaceutical ingredients and intermediates company, has received an Import Alert 66-40 from US Food and Drug Administration (USFDA) for its products manufactured at the company's Unit-II located at Visakhapatnam, Andhra Pradesh on March 20, 2017.

The agency has exempted the following products from the Import Alert-Levetiracetam, Gabapentin, Lamotrigine, Capecitabine, Naproxen sodium, Raltegravir potassium, Atovaquone, Chloropurine, BOC core succinate, 2, 4-wing active ester.

The company along with third party consultants is currently working to address the concerns of the USFDA and is making all efforts to fully meet the compliance requirements. 

Shares of the company declined Rs 138.7, or 17.54%, to trade at Rs 652.00. The total volume of shares traded was 1,228,420 at the BSE (10.02 a.m., Tuesday).



Divis Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Crude oil price of Indian basket falls 4% - 29-May-2017 12:20
Manpasand Beverages to tie-up with Parle Products - 29-May-2017 11:57
Reliance Comm plunges after reporting loss in Q4 - 29-May-2017 11:05
Reliance Comm swings to loss in Jan-Mar quarter - 29-May-2017 11:01
Tech Mahindra tumbles after poor Q4 results - 29-May-2017 10:56
Tech Mahindra quarterly net drops 33% - 29-May-2017 10:51
PSP Projects lists at 9.5% discount - 29-May-2017 10:22
Bank of Baroda to raise Rs 90 bn via equity dilution - 29-May-2017 09:58
Jindal Steel completes 6 MTPA integrated steel plant at Angul - 29-May-2017 09:46
Zydus receives final approval for Acamprosate Ca tablets - 29-May-2017 09:41
Glenmark Pharma gets final nod for generic Bystolic tablets - 29-May-2017 09:22
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer